We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $22.1B
1-Year Est. Return 45.54%
This Fund
S&P 500
This Quarter Est. Return
+4.73%
1 Year Est. Return
+45.54%
3 Year Est. Return
+139.2%
5 Year Est. Return
+180.26%
10 Year Est. Return
AUM
$18.4B
AUM Growth
+$991M
Cap. Flow
+$652M
Cap. Flow %
3.54%
Top 10 Hldgs %
30.84%
Holding
2,900
New
51
Increased
2,117
Reduced
295
Closed
90

Sector Composition

Rank Sector Weight
1 Technology 30.12%
2 Financials 12.96%
3 Consumer Discretionary 11.52%
4 Healthcare 10.04%
5 Industrials 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANDE icon
1526
Andersons Inc
ANDE
$2.21B
$809K ﹤0.01%
19,976
+1,354
+7% +$62.8K
LTH icon
1527
Life Time Group Holdings
LTH
$9.9B
$808K ﹤0.01%
36,538
+2,216
+6% +$53K
KGS icon
1528
Kodiak Gas Services
KGS
$6.26B
$807K ﹤0.01%
19,760
+7,858
+66% +$284K
UVV icon
1529
Universal Corp
UVV
$1.13B
$806K ﹤0.01%
14,691
+621
+4% +$33.3K
SFL icon
1530
SFL Corp
SFL
$1.57B
$804K ﹤0.01%
78,686
+12,901
+20% +$138K
UNIT
1531
Uniti Group
UNIT
$2.31B
$804K ﹤0.01%
146,093
+11,127
+8% +$63.2K
QCRH icon
1532
QCR Holdings
QCRH
$1.73B
$803K ﹤0.01%
9,957
+313
+3% +$26.3K
APPN icon
1533
Appian
APPN
$2.49B
$802K ﹤0.01%
24,325
+1,809
+8% +$64.7K
NRIX icon
1534
Nurix Therapeutics
NRIX
$2.76B
$801K ﹤0.01%
42,539
+7,300
+21% +$167K
AAT
1535
American Assets Trust
AAT
$1.39B
$801K ﹤0.01%
30,503
+1,700
+6% +$46.4K
EVH icon
1536
Evolent Health
EVH
$471M
$798K ﹤0.01%
70,915
+4,185
+6% +$73.5K
HRMY icon
1537
Harmony Biosciences
HRMY
$2.32B
$796K ﹤0.01%
23,127
+5,242
+29% +$180K
AMC icon
1538
AMC Entertainment Holdings
AMC
$2.35B
$796K ﹤0.01%
199,886
+7,060
+4% +$31K
HLX icon
1539
Helix Energy Solutions
HLX
$1.49B
$795K ﹤0.01%
85,270
+1,995
+2% +$20.1K
RVLV icon
1540
Revolve Group
RVLV
$1.69B
$792K ﹤0.01%
23,654
+1,463
+7% +$45.3K
OCUL icon
1541
Ocular Therapeutix
OCUL
$2.25B
$792K ﹤0.01%
92,734
+2,454
+3% +$23.9K
AIV
1542
Aimco
AIV
$379M
$791K ﹤0.01%
87,023
+8,369
+11% +$72.3K
CAR icon
1543
Avis
CAR
$4.93B
$791K ﹤0.01%
9,810
+656
+7% +$59.8K
ATEN icon
1544
A10 Networks
ATEN
$2B
$788K ﹤0.01%
42,803
+2,375
+6% +$38.8K
CSTM icon
1545
Constellium
CSTM
$3.95B
$787K ﹤0.01%
76,659
+1,989
+3% +$24.5K
LNN icon
1546
Lindsay Corp
LNN
$1.18B
$782K ﹤0.01%
6,611
+222
+3% +$27.6K
GDYN icon
1547
Grid Dynamics Holdings
GDYN
$632M
$781K ﹤0.01%
35,126
+1,884
+6% +$32.9K
FOXF icon
1548
Fox Factory Holding Corp
FOXF
$886M
$779K ﹤0.01%
25,737
+1,454
+6% +$50.1K
TVTX icon
1549
Travere Therapeutics
TVTX
$5.79B
$779K ﹤0.01%
44,711
+3,568
+9% +$63.1K
PCT icon
1550
PureCycle Technologies
PCT
$1.41B
$779K ﹤0.01%
75,958
+5,281
+7% +$61.3K

Similar funds

MetLife Investment Management's Q4 2024 Portfolio in Review

As of Q4 2024, MetLife Investment Management held 2,900 positions worth $18.4B, up 5.7% from $17.4B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

MetLife Investment Management deployed $652M of net new capital in Q4 2024, opening 51 new positions and adding to 2,117 existing holdings. Its largest new stake was Flex: 211,786 shares worth $8.13M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Arista Networks, an estimated $13.8M trimmed.

  • MetLife Investment Management's largest Q4 2024 buy was Flex: 211,786 shares worth $8.13M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $117M increase.
  • MetLife Investment Management's biggest Q4 2024 reduction was Arista Networks, cutting an estimated $13.8M.
  • MetLife Investment Management fully exited Southwestern Energy Company in Q4 2024, selling an estimated $4.05M.
  • MetLife Investment Management's ten largest holdings make up 31% of its $18.4B portfolio in Q4 2024.
  • MetLife Investment Management opened 51 new positions and closed 90 in Q4 2024.
  • MetLife Investment Management's portfolio value rose 5.7% quarter-over-quarter to $18.4B.

Based on MetLife Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.